| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 81406 |
t-Butyl acetate-PEG2-CH2COOH,CAS号：883564-93-0 |
141 |
h |
2024-12-24 |
| 81407 |
Azido-PEG8-CH2COO-PFP,CAS号：2182601-80-3 |
107 |
h |
2024-12-24 |
| 81408 |
Control Doxorubicin Liposome (PEGylated),对照阿霉素脂质体(聚乙二醇化) |
147 |
axc |
2024-12-24 |
| 81409 |
Azido-PEG1-CH2CO2H,CAS号：79598-48-4 |
160 |
h |
2024-12-24 |
| 81410 |
Propargyl-PEG4-CH2CO2-NHS,CAS号：2144777-76-2 |
126 |
h |
2024-12-24 |
| 81411 |
Doxorubicin Liposome (PEGylated),阿霉素脂质体(聚乙二醇化) |
1590 |
axc |
2024-12-24 |
| 81412 |
Cbz-NH-PEG3-CH2COOH,CAS号：462100-05-6 |
151 |
h |
2024-12-24 |
| 81413 |
Control High Potency Clodronate Liposome (Anionic),对照高效氯膦酸盐脂质体(阴离子) |
142 |
axc |
2024-12-24 |
| 81414 |
Cbz-NH-PEG2-CH2COOH,CAS号：165454-06-8,8-苄氧羰基氨基-3,6-二氧杂辛酸 |
139 |
h |
2024-12-24 |
| 81415 |
Cbz-NH-PEG5-CH2COOH,CAS号：1449390-66-2 |
131 |
h |
2024-12-24 |
| 81416 |
Cbz-NH-PEG1-CH2COOH,CAS号：1260092-43-0 |
223 |
h |
2024-12-24 |
| 81417 |
Fmoc-NH-PEG12-CH2COOH,CAS号：2291257-76-4 |
132 |
h |
2024-12-24 |
| 81418 |
Boc-NH-PEG1-CH2COOH |
141 |
h |
2024-12-24 |
| 81419 |
Fmoc-NH-PEG11-CH2COOH,CAS号：2629308-66-1 |
100 |
h |
2024-12-24 |
| 81420 |
Boc-Aminooxy-PEG2-CH2COOH,CAS号：2098983-14-1 |
165 |
h |
2024-12-24 |
| 81421 |
11-马来酰胺基十一烷酸，11-Maleimidoundecanoic acid |
138 |
wyh |
2024-12-24 |
| 81422 |
Mc-Val-Cit-PABC-PNP，159857-81-5 ，抗体- 药物偶联物 |
117 |
hyy |
2024-12-24 |
| 81423 |
m-PEG7-(CH2)3-alcohol ，甲氧基-七聚乙二醇-三个亚甲基-乙醇 |
166 |
wyh |
2024-12-24 |
| 81424 |
m-PEG6-(CH2)8-phosphonic acid的化学性质，2028284-71-9 |
103 |
wyh |
2024-12-24 |
| 81425 |
Fmoc-amino-PEG3-CH2COOH,Fmoc-11-氨基-3,6,9-三氧杂十一酸,CAS号：139338-72-0 |
219 |
h |
2024-12-24 |
| 81426 |
Boc-NH-PEG2-CH2COOH,CAS号：108466-89-3,2-[2-(叔丁氧羰基氨基)乙氧基]乙氧基乙酸 |
191 |
h |
2024-12-24 |
| 81427 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester，甲基-六聚乙二醇-(CH2)8-膦酸乙酯 |
148 |
wyh |
2024-12-24 |
| 81428 |
Boc-NH-PEG3-CH2COOH,CAS号：462100-06-7,三氧杂-2-氮杂十三烷二酸-1-叔丁酯 |
146 |
h |
2024-12-24 |
| 81429 |
High Potency Clodronate Liposome (Anionic),高效氯膦酸盐脂质体(阴离子) |
139 |
axc |
2024-12-24 |
| 81430 |
Azido-PEG1-CH2COO-Cl,CAS号：79598-49-5 |
161 |
h |
2024-12-24 |
| 81431 |
Azido-PEG9-CH2COOH |
160 |
h |
2024-12-24 |
| 81432 |
Propargyl-PEG4-(CH2)3-methyl ester ，炔丙基-聚乙二醇（PEG4）-甲酯基团 |
183 |
wyh |
2024-12-24 |
| 81433 |
DiR Labeled Control Clodronate Liposome (Anionic),DiR标记的对照氯膦酸盐脂质体(阴离子) |
246 |
axc |
2024-12-24 |
| 81434 |
Azido-PEG10-CH2COOH |
183 |
h |
2024-12-24 |
| 81435 |
Azido-PEG11-CH2COOH,CAS号：2567584-97-6 |
159 |
h |
2024-12-24 |
| 81436 |
11-(马来酰亚胺基)十一烷酸琥珀酰亚胺酯 ；Maleimide-(CH2)10-COONHS; KMUS |
160 |
wyh |
2024-12-24 |
| 81437 |
DiD Labeled Control Clodronate Liposome (Anionic),DiD标记的对照氯膦酸盐脂质体(阴离子) |
211 |
axc |
2024-12-24 |
| 81438 |
Azido-PEG6-CH2COOH,CAS号：880129-82-8 |
154 |
h |
2024-12-24 |
| 81439 |
DBCO-NHCO-PEG2-CH2COOH |
131 |
h |
2024-12-24 |
| 81440 |
6-马来酰亚胺基己酸 ，Maleimide-(CH2)5-COOH |
136 |
wyh |
2024-12-24 |
| 81441 |
DiA Labeled Control Clodronate Liposome (Anionic),DiA标记的对照氯膦酸盐脂质体(阴离子) |
144 |
axc |
2024-12-24 |
| 81442 |
Br-PEG3-CH2COOH,CAS号：1346502-15-5,溴代四聚乙二醇羧酸 |
131 |
h |
2024-12-24 |
| 81443 |
DiI Labeled Control Clodronate Liposome (Anionic),DiI标记的对照氯膦酸盐脂质体(阴离子) |
150 |
axc |
2024-12-24 |
| 81444 |
Hydroxy-PEG4-CH2COOH sodium salt,CAS号：73349-20-9 |
173 |
h |
2024-12-24 |
| 81445 |
Mal-PEG2-CH2COOH,CAS号：173323-23-4 |
149 |
h |
2024-12-24 |
| 81446 |
Control Clodronate Liposome (Anionic),对照氯膦酸盐脂质体(阴离子) |
248 |
axc |
2024-12-24 |
| 81447 |
Clodronate Liposome (Anionic) 氯膦酸盐脂质体(阴离子) |
540 |
axc |
2024-12-24 |
| 81448 |
Control High Potency Clodronate Liposome (Neutral),对照高效氯膦酸盐脂质体(中性) |
160 |
axc |
2024-12-24 |
| 81449 |
High Potency Clodronate Liposome (Neutral),高效氯膦酸盐脂质体(中性) |
190 |
axc |
2024-12-24 |
| 81450 |
Bromo-PEG7-CH2COOtBu |
154 |
h |
2024-12-24 |
齐岳微信公众号
官方微信
库存查询